Literature DB >> 11788183

Bcl-2 and Bax expression in human endometriotic and adenomyotic tissues.

A Goumenou1, I Panayiotides, I Matalliotakis, I Vlachonikolis, M Tzardi, E Koumantakis.   

Abstract

OBJECTIVE: To determine the Bcl-2 and Bax expressions in endometriotic and adenomyotic tissues. In addition, to evaluate the Bcl-2/Bax status during the menstrual cycle in these tissues.
METHODS: A total of 56 women were retrospectively recruited from a University hospital setting. A total of 25 had endometriosis and 31 adenomyosis. Tissue samples were collected during gynaecological surgery and confirmed by histology to have endometriosis or adenomyosis. Bcl-2 and Bax expressions were investigated on 56 formalin-fixed and paraffin-embedded tissue by immunohistochemical staining and electron microscopy.
RESULTS: The difference of Bcl-2-positive protein between endometriosis and adenomyosis was not significant. No significant difference was found between Bcl-2 expression and the proliferative and secretory phase of the cycle in women with endometriosis, but this comparison was highly significant (P<0.001) in women with adenomyosis. The difference of Bax-positive protein between endometriosis and adenomyosis was not significant. In addition, no significant differences were found between the various phases of the cycle. We have found a stronger inverse correlation between the expression of Bcl-2 and Bax in endometriosis than in adenomyosis.
CONCLUSIONS: Our results suggest that the pathogenesis of ovarian endometriosis may be different from that of adenomyosis and the persistence of Bcl-2 and Bax expressions during both phases of the cycle in ovarian endometriotic tissues may have important implications for the survival and proliferation of the ectopic endometrial tissue.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11788183     DOI: 10.1016/s0301-2115(01)00381-5

Source DB:  PubMed          Journal:  Eur J Obstet Gynecol Reprod Biol        ISSN: 0301-2115            Impact factor:   2.435


  4 in total

1.  Endometrial-peritoneal interactions during endometriotic lesion establishment.

Authors:  M Louise Hull; Claudia Rangel Escareno; Jane M Godsland; John R Doig; Claire M Johnson; Stephen C Phillips; Stephen K Smith; Simon Tavaré; Cristin G Print; D Stephen Charnock-Jones
Journal:  Am J Pathol       Date:  2008-08-07       Impact factor: 4.307

2.  Expression of apoptosis-related proteins in endometriomas and benign and malignant ovarian tumours.

Authors:  Raffaèle Fauvet; Christophe Poncelet; Danièle Hugol; Anne Lavaur; Gérard Feldmann; Emile Daraï
Journal:  Virchows Arch       Date:  2003-05-20       Impact factor: 4.064

3.  Insights into molecular pathways of endometriosis and endometriosis-related ovarian carcinoma.

Authors:  Ioana Păvăleanu; Ludmila Lozneanu; Raluca Anca Balan; Simona Eliza Giuşcă; Elena Roxana Avădănei; Irina Draga Căruntu; Cornelia Amălinei
Journal:  Rom J Morphol Embryol       Date:  2020 Jul-Sep       Impact factor: 1.033

4.  Evaluation of apoptosis and angiogenesis in ectopic and eutopic stromal cells of patients with endometriosis compared to non-endometriotic controls.

Authors:  Ali-Akbar Delbandi; Mahmoud Mahmoudi; Adel Shervin; Sahel Heidari; Roya Kolahdouz-Mohammadi; Amir-Hassan Zarnani
Journal:  BMC Womens Health       Date:  2020-01-06       Impact factor: 2.809

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.